Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

GMP in North America (FDA, Health Canada)

How to Ensure Compliance with FDA and Health Canada’s GMP for OTC Drugs

Posted on May 15, 2025 By digi

How to Ensure Compliance with FDA and Health Canada’s GMP for OTC Drugs Practical Tips for Ensuring GMP Compliance for OTC Drugs under FDA and Health Canada Introduction to GMP Compliance for OTC Drugs Over-the-counter (OTC) drugs are widely available to consumers without a prescription, making their safety, quality, and efficacy critical for public health….

Read More “How to Ensure Compliance with FDA and Health Canada’s GMP for OTC Drugs” »

GMP in North America (FDA, Health Canada)

Best Practices for GMP Documentation in North America

Posted on May 15, 2025 By digi

Best Practices for GMP Documentation in North America Comprehensive Best Practices for GMP Documentation in North America Introduction to GMP Documentation Documentation is a critical component of Good Manufacturing Practices (GMP), ensuring consistency, traceability, and compliance with regulatory requirements. In North America, both the Food and Drug Administration (FDA) and Health Canada emphasize the importance…

Read More “Best Practices for GMP Documentation in North America” »

GMP in North America (FDA, Health Canada)

How to Ensure GMP Compliance for Pharma Manufacturing in Both the US and Canada

Posted on May 15, 2025 By digi

How to Ensure GMP Compliance for Pharma Manufacturing in Both the US and Canada Expert Guide to Achieving GMP Compliance for Pharmaceutical Manufacturing in the US and Canada Introduction to GMP Compliance in North America The pharmaceutical industry in North America is governed by stringent regulatory requirements to ensure the safety, efficacy, and quality of…

Read More “How to Ensure GMP Compliance for Pharma Manufacturing in Both the US and Canada” »

GMP in North America (FDA, Health Canada)

FDA and Health Canada’s GMP Requirements for Drug Imports and Exports

Posted on May 15, 2025 By digi

FDA and Health Canada’s GMP Requirements for Drug Imports and Exports A Complete Guide to FDA and Health Canada GMP Requirements for Drug Imports and Exports Introduction to GMP Compliance for Drug Imports and Exports The pharmaceutical industry operates in a global marketplace where drugs are frequently imported and exported across borders. Ensuring compliance with…

Read More “FDA and Health Canada’s GMP Requirements for Drug Imports and Exports” »

GMP in North America (FDA, Health Canada)

How to Prepare Your Pharmaceutical Facility for FDA GMP Inspections

Posted on May 15, 2025 By digi

How to Prepare Your Pharmaceutical Facility for FDA GMP Inspections Comprehensive Guide to Preparing Your Pharmaceutical Facility for FDA GMP Inspections Introduction to FDA GMP Inspections The Food and Drug Administration (FDA) conducts Good Manufacturing Practices (GMP) inspections to ensure that pharmaceutical facilities meet the highest standards of safety, quality, and compliance. These inspections are…

Read More “How to Prepare Your Pharmaceutical Facility for FDA GMP Inspections” »

GMP in North America (FDA, Health Canada)

FDA GMP Compliance and the Role of Corrective and Preventive Actions (CAPA)

Posted on May 15, 2025 By digi

FDA GMP Compliance and the Role of Corrective and Preventive Actions (CAPA) Mastering FDA GMP Compliance: The Essential Role of CAPA Introduction to FDA GMP Compliance and CAPA In the pharmaceutical industry, compliance with Good Manufacturing Practices (GMP) is critical to ensuring product safety, efficacy, and quality. One of the most effective tools for maintaining…

Read More “FDA GMP Compliance and the Role of Corrective and Preventive Actions (CAPA)” »

GMP in North America (FDA, Health Canada)

FDA and Health Canada GMP: Achieving Regulatory Approval for New Drug Applications

Posted on May 15, 2025 By digi

FDA and Health Canada GMP: Achieving Regulatory Approval for New Drug Applications Understanding FDA and Health Canada GMP Requirements for New Drug Applications Introduction to GMP and Regulatory Approval for New Drug Applications Securing regulatory approval for new drug applications (NDAs) is a rigorous process that requires strict adherence to Good Manufacturing Practices (GMP). Both…

Read More “FDA and Health Canada GMP: Achieving Regulatory Approval for New Drug Applications” »

GMP in North America (FDA, Health Canada)

The Role of FDA’s Drug Approval Process in Ensuring GMP Compliance

Posted on May 15, 2025 By digi

The Role of FDA’s Drug Approval Process in Ensuring GMP Compliance Understanding the Role of FDA’s Drug Approval Process in GMP Compliance Introduction to FDA Drug Approval and GMP Compliance The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry by ensuring that drug products are safe, effective, and of…

Read More “The Role of FDA’s Drug Approval Process in Ensuring GMP Compliance” »

GMP in North America (FDA, Health Canada)

How to Maintain GMP Compliance in Long-Term Pharmaceutical Manufacturing Operations

Posted on May 15, 2025 By digi

How to Maintain GMP Compliance in Long-Term Pharmaceutical Manufacturing Operations Ensuring GMP Compliance in Long-Term Pharmaceutical Manufacturing Operations Introduction to GMP Compliance in Long-Term Operations Maintaining Good Manufacturing Practices (GMP) compliance is a critical requirement for pharmaceutical manufacturers, particularly in long-term operations where consistency, quality, and regulatory adherence must be sustained over time. The Food…

Read More “How to Maintain GMP Compliance in Long-Term Pharmaceutical Manufacturing Operations” »

GMP in North America (FDA, Health Canada)

How FDA and Health Canada’s GMP Guidelines Impact Biotech and Biopharma

Posted on May 15, 2025 By digi

How FDA and Health Canada’s GMP Guidelines Impact Biotech and Biopharma Exploring the Impact of FDA and Health Canada GMP Guidelines on Biotech and Biopharma Introduction to GMP in Biotech and Biopharma The biotechnology and biopharmaceutical industries are at the forefront of innovation, developing complex therapies like monoclonal antibodies, gene therapies, and vaccines. These products…

Read More “How FDA and Health Canada’s GMP Guidelines Impact Biotech and Biopharma” »

GMP in North America (FDA, Health Canada)

Posts pagination

Previous 1 2 3 … 5 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Ensure QA Oversight in Destruction of GMP Rejected Products

    Ensure QA Oversight in Destruction… Read more

GMP in North America (FDA, Health Canada)

  • How FDA GMP Inspections Affect Pharmaceutical Manufacturing Efficiency
  • Health Canada GMP Inspection Process: What to Expect
  • The Importance of Documentation for GMP Compliance in North America
  • The Role of Supplier Quality Management in FDA GMP Compliance
  • The Relationship Between FDA GMP Regulations and Pharmaceutical Packaging
  • How FDA GMP Guidelines Apply to Pharmaceutical Clinical Trials
  • The Role of Risk Management in FDA GMP Compliance
  • How to Navigate GMP Audits by FDA and Health Canada
  • GMP Compliance for Biopharmaceuticals under FDA and Health Canada Regulations
  • FDA GMP Guidelines for Sterile Product Manufacturing

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme